DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Baloxavir marboxil
Baloxavir marboxil
Efficacy of Baloxavir Marboxil on Household Transmission Of
Baloxavir Marboxil: the New Influenza Drug on the Market
Official Title: a Phase III, Randomized, Double-Blind Placebo-Controlled
HIGHLIGHTS from Influenza Update for Urgent Care Preparing Your Center for the 2018-2019 Flu Season
Development of Effective Anti-Influenza Drugs: Congeners and Conjugates – a Review Jiun-Jie Shie1 and Jim-Min Fang2,3*
210854Orig1s000
Clinical Review Melisse Baylor, MD NDA 210854 Baloxavir Marboxil
A Computational Approach to Aid Clinicians in Selecting Anti-Viral
An Influenza a Hemagglutinin Small-Molecule Fusion Inhibitor Identified by a New High-Throughput Fluorescence Polarization Screen
Searching for Target-Specific and Multi-Targeting Organics for Covid
Xofluza, INN-Baloxavir Marboxil
Baloxavir Marboxil) Tablets, for Oral Use
Baloxavir Marboxil
2020: the Year of the Respiratory Viruses a Primer on Influenza and COVID-19
3-Indoleacetonitrile Is Highly Effective in Treating Influenza a Virus
In Vitro Combinations of Baloxavir Acid and Other Inhibitors Against Seasonal Influenza a Viruses
Study Protocol
Xofluza, INN-Baloxavir Marboxil
Top View
Press Release
Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir1
Baloxavir Marboxil Susceptibility of Influenza Viruses from the Asia-Pacific, 2012-2018
Antivirals, Influenza
Missing Clinical Trial Data
Product Information for Baloxavir Marboxil
Baloxavir Marboxil Phase II and III Studies for the Treatment of Influenza Published in the New England Journal of Medicine - Shionogi In…
Antivirals, Influenza
Australian Public Assessment Report for Baloxavir Marboxil
XOFLUZA Patient Product Information
XOFLUZA (Baloxavir Marboxil) Is an Antiviral PA Endonuclease Inhibitor
Assessment of Evidence for COVID-19-Related Treatments
Influenza a and B Viruses with Reduced Baloxavir Susceptibility Display Attenuated in Vitro Fitness but Retain Ferret Transmissibility
Prescribing Information
Characterization of Influenza Virus Variants Induced by Treatment With
NDA 214410/Original 1 & Ndas 210854/S-04, 10; Xofluza
Successful Treatment with Baloxavir Marboxil of a Patient with Peramivir
A Step Forward in the Treatment of Influenza